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Abstract 
This review article shows that coagulase‑negative staphylococci (CoNS) are widely responsible for laryngological 
diseases. General characteristics of CoNS infections are shown in the introduction, and the pathogenicity in terms of 
virulence determinants, biofilm formation and genetic regulation mechanisms of these bacteria is presented in the 
first part of the paper to better display the virulence potential of staphylococci. The PubMed search keywords were 
as follows: CoNS and: nares infections, nasal polyps, rhinosinusitis, necrosing sinusitis, periprosthetic joint infection, 
pharyngitis, osteomyelitis of skull and neck bones, tonsillitis and recurrent tonsillitis. A list of laryngological infections 
and those related to skull and neck bones was presented with descriptions of the following diseases: rhinosinusitis, 
necrotizing sinusitis, nasal polyps, nares and nasal skin infections, periprosthetic joint infections, osteomyelitis, phar‑
yngitis, and tonsillitis. Species identification and diagnostic problems challenging for diagnosticians are presented. 
Concluding remarks regarding the presence of CoNS in humans and their distribution, particularly under the effect of 
facilitating factors, are mentioned.
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General characteristics of coagulase‑negative 
staphylococci (CoNS) infections
The significance of CoNS in infectious medicine became 
apparent in the late 1970s following a series of articles 
on the isolation of these bacteria from diagnostically 
documented infections in humans, as shown by sev-
eral authors [1–6]. The definition of CoNS as a hetero-
geneous group of staphylococci is based on diagnostic 
procedures that fulfil the clinical need to differentiate 
between Staphylococcus aureus, commonly known as 
strongly pathogenic, and other staphylococci classified 
as non- or less pathogenic [7]. CoNS are characterized by 
fewer virulence factors than S. aureus, especially factors 
responsible for aggression, so they are considered less 
pathogenic. However, the virulence of both CoNS and 
coagulase-positive staphylococci (CoPS), represented by 
S. aureus, were compared using various animal models of 
experimental infections [8–13]. The authors showed that 
some CoNS species demonstrated skin lesions similar 
to the lesions generated by S. aureus [11]. Generally, the 
pathogenic potential of CoNS could be accepted when 
both biochemical and genetic molecular methods were 
introduced to analyze the pathogenesis and mechanisms 
of infections [7, 14]. In the last two decades, the medi-
cal importance of this group of bacteria has increased, 
as reported by clinicians and microbiologists [15, 16]. 
There is evidence that CoNS are responsible for a variety 
of infections that differ in localization, manifestation or 
course of infection. However, staphylococcal bacteria are 
opportunistic pathogens that are present in the skin and 
mucous membranes of healthy individuals and become 
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true pathogens mostly for predisposed patients, i.e., 
immunocompromised individuals, patients with cath-
eters, prosthetic implants, dialysis, and oncological dis-
eases, and neonates [17–20].
As pathogens, CoNS are involved in a broad range of 
diseases in deep organs, including bones, the central 
nervous system, the heart or joints [21]. However, CoNS 
are typical opportunistic bacteria that not only colonize 
healthy individuals but also represent one of the major 
hospital pathogens with a substantial increasing impact 
on human life and health [7]. The presence of CoNS in 
the skin and mucous membranes of the host is a main 
source of endogenous infections [7, 22]. In addition, bac-
teria are transmitted among diverse hosts by crossing 
species barriers and during medical procedures, espe-
cially invasive ones [23, 24]. Regarding otorhinolaryn-
gology, CoNS are always present in the skin and mucous 
membranes of the nose, respiratory tract, oral cavity and 
alimentary canal [25, 26]. In the field of laryngology, the 
main papers on CoNS pathogenicity focus on diseases 
such as bacteremia, septicemia, pneumoniae, endocardi-
tis or urinary tract infections, but there are few reports 
on laryngological diseases such as rhinosinusitis and 
sinusitis, both acute and chronic, and infections of the 
frontal sinus, throat, larynx, nares, polyps, tonsils, and 
trachea. A dozen of the over 50 described CoNS species 
have been commonly reported in these diseases, includ-
ing Staphylococcus epidermidis, Staphylococcus haemo-
lyticus, Staphylococcus lugdunensis, Staphylococcus 
warneri, Staphylococcus xylosus, Staphylococcus hominis, 
Staphylococcus capitis, Staphylococcus simulans, Staphy-
lococcus sciuri, Staphylococcus cohnii, Staphylococcus 
lentus, and Staphylococcus chromogenes, although other 
rare species, such as Staphylococcus pettenkoferi, have 
been documented [7, 27, 28].
Pathogenicity: virulence determinants, biofilm 
formation and genetic regulation of CoNS species
CoNS possess numerous diverse strategies to both cause 
infection and survive in the host. In comparison to S. 
aureus, this group of bacteria exhibits lower pathogenic 
potential, but less is known about CoNS virulence mech-
anisms. Recent studies have focused on the ability of 
CoNS to produce a variety of extracellular enzymes, such 
as proteases, elastases, esterases, lipases, and phospholi-
pases [29–32], as well as the production of toxins, such 
as families of hemolysins, enterotoxins, exfoliative toxins, 
and even TSST-1 (Toxic shock syndrome toxin-1) [7, 33–
36]. The enzymes and toxins presented play crucial roles 
in some of the effects of staphylococci on host organ-
isms, including virulence factors in tissue destruction 
and additionally as spreading factors facilitating inva-
sion into nearby tissues. In general, CoNS species lack 
the virulence determinants responsible for aggression, 
but they possess the ability to adhere, invade and persist 
[14, 31]. Furthermore, a critical CoNS property is the 
ability to colonize the surfaces of medical devices by the 
formation of a three-dimensional structured matrix com-
posed of bacteria and extracellular biopolymers-biofilm. 
Increasing evidence suggests that biofilms may form on 
abiotic surfaces of medical devices or on biotic surfaces, 
such as host factor-coated foreign material or host tis-
sue [37, 38]. Biofilm-associated infections are extremely 
difficult to eradicate because within the biofilm, bacteria 
are protected against the immune system of the patient 
and antibiotic therapy [39, 40]. Identification of the fac-
tors that increase CoNS pathogenicity is a great need, 
especially for clinicians and microbiologists. Studies 
described to date have demonstrated that S. epidermidis 
isolates differ regarding antibiotic resistance gene acqui-
sition (e.g., SCCmec), biofilm forming capacities (e.g., 
ica locus), metabolism (e.g., arginine catabolic mobile 
element ACME) and the presence of insertion sequence 
(IS) elements (e.g., IS256) [41–44]. It is very important 
to extend such studies to a larger number of isolates and 
species, but there is strong evidence that horizontal gene 
transfer is responsible for virulence factor transmission 
between species [45–48]. Staphylococcal pathogenesis is 
a process involving an array of extracellular proteins and 
biofilm and cell wall components that are coordinately 
expressed in different phases of infection. The expression 
or suppression of two divergent loci, accessory gene reg-
ulator (agr) and staphylococcal accessory regulator (sar), 
are recognized as key regulators of virulence in staphy-
lococcal infections [49, 50]. The agr system is known to 
modulate virulence factors such as nucleases, proteases, 
lipases and the expression of surface binding proteins, 
and sar can modulate both the agr system and indepen-
dently form an agr locus of cell wall-associated proteins 
such as fibronectin-binding protein, adhesins, protein-A 
and exo-proteins. When the bacterial population is low, 
the expression of adherence proteins is triggered for 
attachment to host tissue and toxins are produced once 
the infection is established [51].
General descriptions of laryngological infections
Laryngology, otolaryngology, is generally a broad medi-
cal discipline that covers the diagnosis, therapy, and 
prophylaxis of diseases of the upper respiratory tract and 
additional organs present in the neck and head, includ-
ing throat, larynx, nose, ears, and other organs in these 
parts of body [52]. Recently, important medical ques-
tions in laryngology have been raised regarding oncologi-
cal and infectious diseases [53, 54]. Statistically viral and 
bacterial infections of the respiratory tract that spread 
into other anatomical niches are the most identified 
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in epidemiological analysis. Staphylococci, particu-
larly CoNS, can cause local infections, but they are also 
responsible for pathological complications after expand-
ing from laryngological areas to other areas, including 
skin, and heart, and even sepsis in newborns as well as 
nosocomial infections [55–61]. Moreover, an increasing 
number of fungal infections has recently been reported 
in laryngology studies, and these infections are related 
to the overconsumption of antibiotics and patients with 
immune disorders.
Rhinosinusitis
The rhinosinus is the space in the front part of the facial 
skeleton that is filled with air and mucous membranes 
with ciliated epithelium, including mucous glands. In 
addition, inflammation proceeds synchronously because 
of the anatomical and physiological relations of the 
mucous membranes of the nose and rhinosinus, which 
is the reason for the Latin name used for inflammation 
of mucous membranes of nose and rhinosinus–rhinosi-
nusitis. Acute rhinosinusitis (ARS) appears the most 
frequently in the course of viral cold disease, whereas 
chronic rhinosinusitis (CRS) is a common source of 
CoNS isolation [62]. CRS represents a heterogeneous 
group of diseases resulting from the multifaceted inter-
actions between the individual patient and environ-
ment. Chronic rhinosinusitis is one of the most common 
chronic disorders, present in up to 28% of European or 
American populations [63]. The mechanisms of this dis-
ease are still under careful molecular analysis. The main 
underlying causes of rhinosinusitis are various bacteria, 
but the most commonly isolated are gram-positive cocci. 
The predominant organisms identified are streptococci 
and staphylococci. Bacterial infection plays an impor-
tant role in CRS as either a causative or exacerbating fac-
tor [64, 65]. However, the role of CoNS in CRS remains 
“controversial” [66]. For a significant subpopulation of 
patients, only CoNS were isolated, while another popula-
tion had other positive cultures, and a small group had 
no bacterial growth [66].
Microbiological analysis of samples from CRS patients 
revealed that mainly CoNS were identified, followed by S. 
aureus and gram-negative rods, including Pseudomonas 
aeruginosa, Stenotrophomonas maltophilia, Escherichia 
coli, and Serratia marcescens [65]. The most frequently 
found CoNS species in CRS patients was S. epidermidis, 
and other CoNS, such as S. lugdunensis, S. capitis, Staph-
ylococcus saprophyticus, S. haemolyticus, and Staphylo-
coccus saccharolyticus and to a lesser degree other minor 
CoNS, were present in 87% of cases [63, 67].
Molecular genetic studies have shown that the patho-
logic ability of CoNS such as S. epidermidis depends on 
genes associated with biofilm formation that have only 
been found in certain strains [68]. However, knowledge 
of the importance of bacteria and microbial biofilms in 
the etiology of CRS is still incomplete. Some authors 
have determined the association between positive 
CoNS culture at the time of functional endoscopic sinus 
surgery (FESS) and CRS severity. Simultaneously, bac-
teria other than CoNS have been isolated: Streptococcus 
pneumoniae (30–70%), Streptococcus pyogenes (3–7%), 
Streptococcus spp., Moraxella catarrhalis (12–28%), 
Enterobacter spp., Cutibacterium acnes [66], S. aureus 
(27%), Haemophilus influenzae (27%), P. aeruginosa 
(22%), Peptostreptococcus spp. (20%), Bacteroides spp. 
(19%), Klebsiella pneumoniae (11%), and E.coli (11%) 
[69]. Other authors analyzed the exacerbation of CRS in 
125 patients and identified CoNS as the most common 
organism, followed by S. aureus [70]. Studies on cul-
tures from 394 CRS patients revealed that aerobes were 
predominant, and CoNS were common (24%), followed 
by S. aureus (19%) and Streptococcus viridans (10%) 
[71]. Despite the high prevalence of CoNS and their 
controversial effect on CRS, some reports have shown 
that the bacteria as the sole positive culture result did 
not result in increased CRS disease burden [66]. The 
presence of CoNS alone was independently associated 
with no history of prior FESS. However, some authors 
showed no significant difference in CRS disease severity 
between patients with CoNS as the sole positive culture 
result and no bacterial growth, but phenomena such 
as horizontal virulence gene transfer, quorum sensing, 
and mechanisms of gene expression/suppression neces-
sitate further studies on a larger number of patients and 
isolates to evaluate whether the effect of CoNS differs 
in various subgroups [66, 69]. The role of CoNS in CRS 
pathogenesis is not completely understood because 
the bacteria that colonize the nasal cavity under physi-
ological conditions have been interpreted as contami-
nation in microbiological analysis by few authors. Most 
authors have reported an important role for CoNS in 
CRS pathogenesis and the mechanism of the disease 
because of the extracellular production of virulence fac-
tors such enzymes and toxins, biofilm formation, and 
virulence or resistance gene transfer among the bacte-
ria colonizing these anatomical areas. However, there 
are few factors that may affect the detection of CoNS as 
etiological factors in such infections. The frequency of 
CoNS isolation at the infection site and the molecular 
typing of CoNS to determine the clonality of the iso-
lates is crucial in determining the real etiological factor. 
Moreover, the presence of invasive medical devices and 
the immune status of patients should be considered, as 
immunocompromised patients are more susceptible to 
CoNS infection.
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Necrotizing sinusitis
Necrosing sinonasal infection often involves infectious 
agents such as viruses, bacteria, fungi, and parasites [72–
74]. However, the only reported CoNS species respon-
sible for acute necrotizing sinusitis is S. lugdunensis, 
which was reported in hospitalized patients with meta-
static prostate adenocarcinoma [75]. Additionally, severe 
acute necrotizing sinusitis was complicated by periorbital 
cellulitis and ulceration from the maxillary sinus to the 
hard palate. The only pathogen to be identified in three 
independent biopsy samples was S. lugdunensis [75]. The 
species identification of organisms was verified by the 
Health Protection Agency Respiratory and Systematic 
Infection Reference Laboratory using advanced method-
ology. Interestingly, S. lugdunensis, in addition to being 
a skin commensal of the limbs, groin and nose vestibule 
of healthy adults, has also been isolated from acute oral 
infections [76], prosthetic joints, endovascular, skin and 
soft tissue infections; in individual cases, S. lugdunenesis 
has been isolated as an agent of osteomyelitis, which can 
lead to laryngological implications in terms of significant 
effects on the head or face bones. Moreover, S. lugdunen-
sis is a major pathogen for heart valves, both native and 
prosthetic, as it causes very aggressive endocarditis [75, 
77].
Nasal polyps
Many staphylococci colonize the human nose vestibule; 
however, the main question relates to S. aureus, as it is 
unknown whether and how this bacterium adapts to this 
particular ecological niche during colonization. Staphy-
lococci are among the bacterial species associated with 
increasing invasive diseases and drug resistance distri-
bution in humans [78]. The analysis of the composition 
of the human nasal culturome revealed that S. epider-
midis colonizes almost all individuals (97%), followed 
by S. haemolyticus (44%), S. hominis and S. capitis (each 
41%), S. warneri (32%) and S. lugdunensis (26%) [79]. 
The basis of colonization with strains carrying virulence 
determinants and/or resistance results from fibronec-
tin-, fibrinogen-, and collagen-binding surface proteins 
responsible for adhesion and further infection [80]. Pol-
yps are abnormal growth tissue complexes that originate 
from mucous membranes and are generally present in 
any organ. In laryngology, polyps are interpreted as dis-
orders or lesions of an inflammatory nature or caused 
by injury; most cases involve a history of trauma [81]. 
Therefore, polyps occur elsewhere in the body where 
there is a mucous membrane. The presence of polyps and 
accompanying mucosal edema is one of the main obser-
vations at examination [82]. The polyps may be involved 
in chronic sinusitis. CRS with polyps can be present not 
as a single disease entity but as nasal symptoms of many 
different diseases [83]. Environmental microorganisms 
affect the host and cause symptoms in CRS. Bacteria 
involved in the disease play an important role, and bacte-
rial biofilms present in CRS patients are responsible for 
noneffective therapy even after surgical and antibiotic 
interventions [63]. A group of patients with nasal pol-
yps may have different disease etiologies, and it is well 
documented that culture results are difficult in post-
ESS patients. CRS patients with CoNS as the sole posi-
tive culture result were significantly more likely to have 
nasal polyps [66]. Analysis of the bacteriological profile of 
the patients showed that CoNS, S. aureus, Streptococcus 
sp., Haemophilus sp., Enterobacter sp., and Corynebac-
terium sp. appear to be more frequently associated with 
patients with chronic rhinosinusitis (CRS) with nasal 
polyps than with patients with CRS without nasal polyps 
or control individuals, where the most common aerobic 
bacteria were CoNS, Corynebacterium spp., S. aureus, 
and H. influenzae. Additionally, few anaerobic bacteria 
and fungi have been isolated from various study groups 
[84]. Authors of another project reported no significant 
differences in isolation rates among three groups of CRS 
patients, i.e., with polyps, without polyps, and the control 
group, although the two most common bacterial species 
were CoNS and Corynebacterium spp. in CRS with pol-
yps group; CoNS, Corynebacterium spp., and S. aureus in 
CRS without polyps group; and CoNS, and S. aureus in 
the control group. Finally, CoNS were the most common 
species among the three groups [85].
Nares and nasal skin infections
The human nares and skin flora are normally largely 
composed of different species of CoNS and coryneforms, 
as reported by many authors [1, 2, 86–88]. Among all 
aerobic bacteria, CoNS are the group of organisms with 
the best characteristics for growth and multiplication 
in cutaneous recesses enriched with sebum and sweat 
because of the many extracellular enzymes they produce, 
enabling the use of skin substrates, particularly neutral 
fatty acids of sebum [89–91]. Infections with Staphylo-
coccus bacteria can result in a variety of skin conditions, 
including cellulitis, furuncles, impetigo or staphylococcal 
scalded skin syndrome (SSSS). Some CoNS strains, such 
as S. epidermidis and S. haemolyticus, share the same 
habitats as S. aureus and permanently or transiently colo-
nize the anterior nares, nose vestibule, and other regions 
of skin and mucous membranes, acting as a source of 
infection [92]. Therefore, both S. aureus and CoNS are 
often recovered from the same diagnostic specimen in 
parallel [93].
CoNS infections of nares or nasal skin have been 
reported in a minority of cases in comparison to S. 
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aureus infections, and they are always combined with 
immunocompromised or directly post-surgery hospital-
ized patients [94, 95]. Common types of nasal staphylo-
coccal infections include folliculitis, which is an infection 
of one or many hair follicles; furuncle, also known as 
boils, which are deep infections around the hair follicle or 
oil glands that contain pus; or nasal vestibulitis, an infec-
tion of the front area of the nasal cavity that may cause 
crusting and bleeding. There are various symptoms of 
nasal staphylococcal infections, such as crusting, swell-
ing, lesions with pus secretion, light bleeding, pain, red-
ness or fever [96]. Therefore, nasal carriage of CoNS, 
especially methicillin-resistant CoNS, appears to play a 
key role in the epidemiology and pathogenesis of infec-
tions in nares or upper respiratory tracts [94]. Increasing 
evidence suggests that nasal CoNS are also reservoirs for 
mupirocin resistance, which may therefore be transmit-
ted to S. aureus. Mupirocin is the first-line drug treat-
ment to eradicate S. aureus nasal colonization, which 
may fail, although rarely, due to the transfer of underlying 
genetic elements from CoNS to S. aureus [97, 98]. Over 
the last few years, CoNS have become important as caus-
ative agents of hospital-acquired bacteremia and surgical 
site infections. Thus, CoNS colonizing anterior nares and 
skin are severe pathogens responsible for infections and 
are additionally often associated with multiple antimicro-
bial-resistance mechanisms, including antibiotic resist-
ance of various other pathogens [51, 52].
Periprosthetic joint infections
In laryngology, temporomandibular joint (TMJ) infec-
tions are still a challenge, because there is no single lead-
ing disease [99]. The TMJ joins the mandible with the 
skull, and pain can mimic infections of the inner ear. 
The TMJ is part of a larger system known as the stoma-
tological system or locomotor system of the masticatory 
apparatus. This is a very complex system under perma-
nent and dynamic changes throughout life. Infections of 
the TMJ in both intracapsular and pericapsular courses 
are rare diseases [100]. The predisposing factors for con-
tributing to TMJ infections are divided into local factors, 
such as blunt trauma, history of joint diseases and burn, 
and systemic factors including autoimmune disease and 
overconsumption of medicines with special reference to 
steroids [57, 101, 102]. Therefore, there are various rea-
sons for TMJ infections; however, it is difficult to indicate 
the most important. Some authors have shown fatigue 
of TMJ muscles, orthodontic disorders, trauma of the 
head or spine, and stress as reasons for TMJ infections 
[103]. Analysis of ankylosis and arthritis showed that 
the most common causes of the disease are trauma and 
infection [104], and psychological aspects have also been 
reported as factors in nonorganic TMJ dysfunction [105]. 
The invasion of bacteria into the joint space can occur 
through several routes, but hematogenous spread indi-
cates that blood circulation is the most common route. 
The other methods are adjacent, contiguous infected 
tissues and direct centesis into the joint cavity by direct 
inoculation [100]. Among these, the most prevalent route 
is hematogenous spread originating from primary infec-
tion sites [106]. The typical bacteria causing TMJ infec-
tions are Streptococcus spp., S. aureus, S. epidermidis, 
Neisseria gonorrhoeae, H. influenzae, and P. aeruginosa 
[107, 108]. The tests used to confirm species identifica-
tions showed that CoNS, such as S. lugdunensis, S. epi-
dermidis, S. haemolyticus, S. xylosus, S. warneri, and S. 
hominis, were isolated from fluid secreted by the tem-
poromandibular joint of patients with muscle pain [109]. 
Additionally, S. capitis, a multidrug-resistant strain with 
documented potential for both human disease and noso-
comial spread, was isolated from a group of patients 
[110]. An accompanying chronic orofacial muscle pain is 
associated with membrane-damaging toxins from CoNS 
(MDT-CoNS) or S. aureus. Previous reports suggest 
that membrane-damaging toxins produced by CoNS are 
associated with the development of chronic disease [111, 
112]. Additionally, an evaluation in the distribution of 
Staphylococcus spp. in different phases of prosthetic joint 
infection (PJI) was observed, and the predominant path-
ogens were CoNS followed by S. aureus. Almost equal 
proportions of CoNS and S. aureus were observed in the 
delayed phase. CoNS were the predominantly identi-
fied organisms in the early phase, whereas S. aureus was 
observed primarily in the late phase [113]. In many medi-
cal disciplines, such as infectious laryngology, orthopedic 
infections due to CoNS presenting antibiotic-resistant 
profiles are increasing. Soft tissues and bone implant-
associated infections are caused by CoNS, with the most 
prevalent species being S. epidermidis. These infections 
are considered difficult to treat because of the ability of 
the bacteria to grow in biofilms and form small-colony 
variants, including persistent organisms [114, 115].
Osteomyelitis
The discipline of laryngology also concerns diseases of 
the skull and neck bones. Osteomyelitis generally refers 
to laryngology-related inflammatory diseases of bones 
caused by microorganisms and leads to bone destruction. 
The most frequent microorganisms isolated from osteo-
myelitis are S. aureus and CoNS, with a predominance 
of S. epidermidis [116]. However, a new CoNS species, S. 
pettenkoferi, has been described as causing human osteo-
myelitis [117]. The disease otitis or otitis externa can 
also cause complications such as skull base osteomyelitis 
(SBO) [118]. In particular, orthopedic devices are used 
for bone fixation or joint replacement and are receptive/
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susceptible to commensal bacteria, mainly CoNS. The 
therapy of such infections is expensive, and the infections 
result in high patient morbidity [119]. Bone infections 
caused by CoNS are associated with a high prevalence of 
methicillin resistance, and broad spectrum oral antibiosis 
was demonstrated in a predominantly diabetic popula-
tion [116]. In advanced laryngology concerning surgical 
reconstructions of bones and/or accompanying soft tis-
sues, infections due to CoNS and methicillin-resistant 
strains are increasing [114]. CoNS are often responsible 
for cases of chronic osteomyelitis and otitis, especially in 
patients with orthopedic prostheses or implants. Chronic 
courses of osteomyelitis or ostitis were caused by the fol-
lowing CoNS species: S. epidermidis, S. haemolyticus, 
S. simulans, S. warneri, S. sciuri, S. cohnii, S. hominis, S. 
lentus, S. chromogenes, and S. pettenkoferi [120]. Addi-
tionally, other chronic forms of osteomyelitis such as 
suppurative osteomyelitis of the jaws are caused by vari-
ous bacteria, with a significant portion being CoNS [121].
Pharyngitis, throat infection
Pharyngitis is a disease of the throat, infection and 
inflammation caused by viruses, eubacteria, or Myco-
plasma pneumoniae. The bacteria, that cause these 
infections include group A/C/G/B streptococci, Fusobac-
terium, and N. gonorrhoeae, but Str. pyogenes and other 
streptococci are the predominant species [52]. CoNS are 
generally considered nonpathogenic, and their presence 
in clinical material has been interpreted as contamina-
tion by normal microbiota present in the mucous mem-
branes of the oral cavity and upper respiratory tracts. 
However, there are few reports on CoNS in cultures from 
throat infections, but these studies were mostly in chil-
dren, and the role of CoNS as causative agents should be 
further investigated [122–124].
Tonsillitis (T) and recurrent tonsillitis (RT) are caused 
by viruses, bacteria, Chlamydia and fungi. The symp-
toms of tonsillitis and pharyngitis are similar. The most 
frequently isolated organisms from T or RT are S. aureus 
strains, from 70% of patients, followed by Streptococcus 
sp. from groups A, B, and C (and G), and the following 
species dominant as well: beta-hemolytic Str. pyogenes, 
H. influenzae, Haemophilus parainfluenzae, Klebsiella 
pneumoniae, Klebsiella oxytoca, Moraxella catarrhalis, 
Citrobacter koseri, Enterobacter cloacae, Enterobacter 
aerogenes, E.  coli, and P. aeruginosa [125–127]. Aside 
from streptococci, all other species are considered able 
to colonize the throat and could be found in recurrent 
tonsillitis due to gastroesophageal reflux. CoNS have also 
been isolated in cultures from T and RT infections, but 
they are reported as accompanying bacteria and culture 
contaminants [128, 129]. Such results and the involve-
ment of S. aureus in the etiology of T and RT have not 
yet been fully understood because CoNS and occasion-
ally S. aureus constantly colonize mucous membranes of 
the oral cavity and upper respiratory tracts. Furthermore, 
staphylococcal internalizations in deeper layers or even 
inside of tonsils, as well as in single cells of patients, have 
been observed [125, 130].
Species identification and diagnostics problems
Challenging identification processes may lead to a lack 
of noted infections caused by staphylococci other than 
S. aureus and their spread in the environment. Com-
monly used routine diagnostic methods, such as cul-
ture-dependent phenotypic tests, including automated 
systems such as Vitek 2 (bioMérieux, La Balme Les 
Grottes, France), BD Phoenix (BD Diagnostic Systems, 
Sparks, MD, USA), and matrix-assisted laser desorption 
ionization–time of flight mass spectrometry (MALDI-
TOF MS), both with 16S rRNA gene sequencing, are usu-
ally not precise enough to carefully assign Staphylococcus 
species [28, 131–134]. Many members of the Staphylo-
coccus genus are closely phylogenetically related, and the 
real impact of CoNS species as infectious etiological fac-
tors may remain underreported. The implementation of 
reliable genetic methods in clinical practice will improve 
the identification process and result in faster and more 
precise diagnosis of staphylococcal infections. As shown 
in our review article, in laryngological infections, staphy-
lococci often coexist with other opportunistic and patho-
genic bacteria, complicating the identification process. 
The new genetic diagnostics approach, based on next 
generation sequencing, may be used for the identification 
of whole species content in polymicrobial clinical sam-
ples. The well-curated and publicly available reference 
sequence dataset for Staphylococcus species will allow the 
introduction of this approach in all microbiological labo-
ratories with access to NGS (next-generation sequencing) 
platforms and may be used in diagnosing laryngological 
infections [28, 135, 136].
Concluding remarks
CoNS are a heterogeneous group of gram-positive bac-
teria that colonize human or animal skin and mucous 
membranes and are distributed from these niches into 
the environment. Although CoNS are present every-
where, they multiply in humans or animals only. Under 
physiological conditions, CoNS are typical saprophytes, 
but under exposure to additional conditions, known as 
infection-facilitating factors, their character changes 
from saprophytic to pathogenic. Therefore, CoNS are 
responsible for various infections of different localiza-
tions, manifestations or courses. This review article 
showed that CoNS are widely present in laryngological 
diseases. Their presence in clinical materials originating 
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from laryngological patients presents a new challenge for 
both clinicians and microbiologists; showing these bac-
teria in new light. Known in the past as “skin staphylo-
cocci”, CoNS were interpreted as accompanying bacteria 
or contamination in diagnostic samples. Today, based on 
recent reports from advanced microbiological laborato-
ries using molecular diagnostic methods, it is known that 
CoNS are severe pathogens and require increased infec-
tion prevention programs with hygiene discipline in hos-
pitals. Moreover, improved didactic programs are needed 
to better understand the role of CoNS in laryngological 
diseases with the primary aim of reducing the number of 
staphylococcal infections in patients.
Abbreviations
ACME: Arginine catabolic mobile element; agr: Accessory gene regulator; 
ARS: Acute rhinosinusitis; CoNS: Coagulase‑negative staphylococci; CoPS: 
Coagulase‑positive staphylococci; CRS: Chronic rhinosinusitis; FESS: Functional 
endoscopic sinus surgery; IS: Insertion sequence; MDT‑CoNS: Membrane‑
damaging toxins from coagulase‑negative staphylococci; NGS: Next‑Gen‑
eration Sequencing; PJI: Prosthetic joint infection; RT: Recurrent tonsillitis; 
sar: Staphylococcal accessory regulator; SBO: Skull base osteomyelitis; SSSS: 
Staphylococcal scalded skin syndrome; T: Tonsillitis; TMJ: Temporomandibular 




MM, JM and MKS reviewed previous studies and wrote the manuscript. AS and 
VS improved and reviewed clinical part of the manuscript. APK investigated 
the scientific literature in terms of laryngological infections. All authors read 
and approved the final manuscript.
Funding
Not applicable.
Availability of data and materials
Not applicable.





The authors declare that they have no competing interests.
Author details
1 MML Medical Centre, Warsaw, Poland. 2 Clinical Microbiology and Virology, 
Spirito Santo Hospital, Pescara, PE, Italy. 3 Department of Microbiology, Faculty 
of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, 
Poland. 
Received: 22 January 2020   Accepted: 25 May 2020
References
 1. Kloos WE, Schleifer KH. Isolation and characterization of staphylococci 
from human skin. II Descriptions of four new species: Staphylococcus 
warneri, Staphylococcus capitis, Staphylococcus hominis and Staphylococ-
cus simulans. Int J Syst Bacteriol. 1975;25:62–79.
 2. Schleifer KH, Kloos WE. Isolation and characterization of staphylococci 
from human skin: I Amended descriptions of Staphylococcus epidermidis 
and S. saprophyticus and descriptions of three new species: Staphylo-
coccus cohnii, Staphylococcus haemolyticus and Staphylococcus xylosus. 
Int J Syst Bacteriol. 1975;25:50–61.
 3. Ogston A. On Abscesses. Rev Infect Dis. 1984;6:122–8.
 4. Devriese LA, Devos AH, Beumer J, Maes R. Characterisation of staphylo‑
cocci isolated from poultry. Poult Sci. 1972;51(2):389–97.
 5. Sompolinsky D, Boldur I, Lagziel A, Halperin Y, Caspi E. A series of sepsis 
due to Staphylococcus aureus after abdominal hysterectomy. Am J 
Obstet Gynecol. 1979;133(8):931–2.
 6. Kloos WE, Bannerman TL. Update on clinical significance of coagulase‑
negative staphylococci. Clin Microbiol Rev. 1994;7(1):117–40.
 7. Becker K, Heilmann C, Peters G. Coagulase‑negative staphylococci. Clin 
Microbiol Rev. 2014;27:870–926. https ://doi.org/10.1128/CMR.00109 ‑13.
 8. Aly R, Maibach HI, Shinefield HR, et al. Protection of chicken embryos by 
viridans streptococci against the lethal effect of Staphylococcus aureus. 
Infect Immun. 1974;9(3):559–63.
 9. McCabe WR. Bacterial interference induced in embryonated eggs by 
staphylococci. J Clin Invest. 1967;46(3):453–62.
 10. Międzobrodzki J, Tadeusiewicz R, Heczko PB. Virulence of coagulase‑
negative Staphylococci for chick embryos. Zbl Bakt Suppl 14, In: The 
Staphylococci, Ed. Jeljaszewicz J, Fisher Verlag G, Stuttgart, New York 
1985; 477‑480
 11. Międzobrodzki J, Tadeusiewicz R. Staphylococcal dermonecrotic reac‑
tions in guinea pigs. Int J Bio Med Comput. 1987;21:67–74.
 12. Międzobrodzki J, Tadeusiewicz R. Estimation of staphylococcal patho‑
genicity for chick embryos. Acta Biol Cracov Ser Bot. 1988;1(1):1–8.
 13. Yu W, Kim HK, Rauch S, Schneewind O, Missiakas D. Pathogenic 
conversion of coagulase‑negative staphylococci. Microbes Infect. 
2017;19(2):101–9. https ://doi.org/10.1016/j.micin f.2016.12.002.
 14. Heilmann C, Ziebuhr W, Becker K. Are coagulase‑negative staphylo‑
cocci virulent? Clin Microbiol Infect. 2019;25(9):1071–80. https ://doi.
org/10.1016/j.cmi.2018.11.012.
 15. Fontana C, Favaro M. Coagulase‑positive and coagulase‑negative 
staphylococci in human disease, in Pet‑to‑Man travelling staphylococci: 
A world in progress, ed V. Savini (Cambridge, MA: Elsevier), 2018; 25–42. 
https ://doi.org/10.1016/b978‑0‑12‑81354 7‑1.00003 ‑0.
 16. Kosecka‑Strojek M, Buda A, Międzobrodzki J. Staphylococcal ecology 
and epidemiology, in Pet‑to‑Man travelling staphylococci: A World in 
Progress, ed V. Savini (Cambridge, MA: Elsevier), 2018; 11–24. https ://doi.
org/10.1016/b978‑0‑12‑81354 7‑1.00002 ‑9.
 17. Białecka A, Kasprowicz A. Bacterial flora of respiratory tract infections. 
Med Dosw Mikrobiol. 1994;46(1–2 Suppl):59–66.
 18. Dubois D, Leyssene D, Chacornac JP, et al. Identification of a variety of 
Staphylococcus species by matrix‑assisted laser desorption ionization‑
time of flight mass spectrometry. J Clin Microbiol. 2010;48(3):941–5.
 19. Huebner J, Goldmann DA. Coagulase‑negative staphylococci: role as 
pathogens. Annu Rev Med. 1999;50:223–36.
 20. Grzebyk M, Brzychczy‑Włoch M, Piotrowska A, Krzyściak P, Heczko PB, 
Bulanda M. Phenotypic evaluation of hydrophobicity and the ability 
to produce biofilm in coagulase‑negative staphylococci isolated 
from infected very‑low‑birth weight newborns. Med Dow Mikrobiol. 
2013;65(3):149–59.
 21. Casey AL, Lambert PA, Elliott TS. Staphylococci. Int J Antimicrob Agents. 
2007;29(Suppl 3):S23–32.
 22. Josse J, Laurent F, Diot A. Staphylococcal adhesion and host cell inva‑
sion: Fibronectin‑binding and other mechanisms. Front Microbiol. 
2017;8:2433. https ://doi.org/10.3389/fmicb .2017.02433 (eCollection 
2017).
 23. Jenkins SN, Okello E, Rossitto PV, Lehenbauer TW, Champagne J, et al. 
Molecular epidemiology of coagulase‑negative Staphylococcus species 
isolated at different lactation stages from dairy cattle in the United 
States. Peer J. 2019;7:6749. https ://doi.org/10.7717/peerj .6749 (eCollec-
tion 2019).
 24. GómezSanz E, Ceballos S, RuizRipa L, Zarazaga M, Torres C. Clonally 
diverse methicillin and multidrug resistant coagulase negative staphy‑
lococci are ubiquitous and pose transfer ability between pets and their 
owners. Front Microbiol. 2019;10:485. https ://doi.org/10.3389/fmicb 
.2019.00485 (eCollection 2019).
Page 8 of 10Michalik et al. Ann Clin Microbiol Antimicrob           (2020) 19:26 
 25. Górecka A, Nowiński A, Augustynowicz‑Kopeć E. Microbiom of the 
lung. Pneumol Alergol Pol. 2014;82:481–5.
 26. Malinowska M, Tokarz‑Deptuła B, Deptuła W. The respiratory tract micro 
biota in physiological and pathological conditions. Post Mikrobiol. 
2016;55(3):279–83.
 27. Parte AC. LPSN‑list of prokaryotic names with standing in nomenclature 
(bacterio.net), 20 years on. Int J Syst Evol Microbiol. 2018;68:1825–9.
 28. Kosecka‑Strojek M, Sabat AJ, Akkerboom V, Becker K, van Zanten E, 
et al. Development and validation of a reference data set for assigning 
staphylococcus species based on next‑generation sequencing of the 
16S‑23S rRNA region. Front Cell Infect Microbiol. 2019;9:278. https ://doi.
org/10.3389/fcimb .2019.00278 .
 29. Bonar E, Międzobrodzki J,Władyka B. The Staphylococcal coagulases. 
In: Pet‑to‑Man travelling staphylococci. A world in progress, ed V. Savini 
(Cambridge, MA: Elsevier), 2018; 95–102. https ://doi.org/10.1016/b978‑
0‑12‑81354 7‑1.00007 ‑8.
 30. Lepidi A. Staphylococcal lipases. In: Pet‑to‑man travelling staphylo‑
cocci. A world in progress, ed V. Savini (Cambridge, MA: Elsevier), 2018; 
147–159. https ://doi.org/10.1016/b978‑0‑12‑81354 7‑1.00012 ‑1.
 31. Międzobrodzki J, Naidu AS, Watts JL, Ciborowski P, Palm K, Wadström T. 
Effect of milk on fibronectin and collagen type I binding to Staphylococ-
cus aureus and coagulase‑negative staphylococci isolated from bovine 
mastitis. J Clin Microbiol. 1989;27(3):540–4.
 32. Stach N, Kaszycki P, Władyka B, Dubin G. Extracellular proteases of 
Staphylococcus spp. In: Pet‑to‑man travelling staphylococci. A world in 
progress, ed V. Savini (Cambridge, MA: Elsevier), 2018; 135–145. https ://
doi.org/10.1016/b978‑0‑12‑81354 7‑1.00011 ‑x.
 33. Kreiswirth BN, Schlievert PM, Novick RP. Evaluation of coagulase‑nega‑
tive staphylococci for ability to produce toxic shock syndrome toxin 1. J 
Clin Microbiol. 1987;25:2028–9.
 34. Bukowski M, Władyka B, Dubin A, Dubin G. The Staphylococcal exfolia‑
tive toxins in: Pet‑to‑Man travelling Staphylococci. A world in progress, 
ed V. Savini (Cambridge, MA: Elsevier), 2018; 127–133. https ://doi.
org/10.1016/b978‑0‑12‑81354 7‑1.00010 ‑8.
 35. Nawrotek P, Karakulska J, Fijałkowski K. The Staphylococcal Panton‑Val‑
entine leukocidin (PVL). In: Pet‑to‑man travelling staphylococci. A world 
in progress, ed V. Savini (Cambridge, MA: Elsevier), 2018; 117–125.
 36. Pontieri A. Staphylococcal Lipases. In: Pet‑to‑man travelling staphylo‑
cocci. A World in Progress, ed V. Savini (Cambridge, MA: Elsevier), 2018; 
147–159. https ://doi.org/10.1016/b978‑0‑12‑81354 7‑1.00008 ‑x.
 37. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase‑
negative staphylococci on surfaces of intravenous catheters. J Infect 
Dis. 1982;146:479e82.
 38. Arrecubieta C, Asai T, Bayern M, Loughman A, Fitzgerald JR, Shelton 
CE, et al. The role of Staphylococcus aureus adhesins in the patho‑
genesis of ventricular assist device‑related infections. J Infect Dis. 
2006;193:1109e19.
 39. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, 
et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus 
epidermidis against major components of the human innate immune 
system. Cell Microbiol. 2004;6(3):269–75.
 40. Arciola CR, Campoccia D, Montanaro L. Implant infections: adhe‑
sion, biofilm formation and immune evasion. Nat Rev Microbiol. 
2018;16(7):397–409. https ://doi.org/10.1038/s4157 9‑018‑0019‑y.
 41. Ziebuhr W, Heilmann C, Gotz F, Meyer P, Wilms K, et al. Detection of the 
intercellular adhesion gene cluster (ica) and phase variation in Staphy-
lococcus epidermidis blood culture strains and mucosal isolates. Infect 
Immun. 1997;65(3):890–6.
 42. Frebourg NB, Lefebvre S, Baert S, Lemeland JF. PCR‑Based assay for 
discrimination between invasive and contaminating Staphylococcus 
epidermidis strains. J Clin Microbiol. 2000;38:877e80.
 43. Galdbart JO, Allignet J, Tung HS, Ryden C, El Solh N. Screening for 
Staphylococcus epidermidis markers discriminating between skin‑flora 
strains and those responsible for infections of joint prostheses. J Infect 
Dis. 2000;182:351e5.
 44. Barbier F, Lebeaux D, Hernandez D, Delannoy AS, Caro V, François P, et al. 
High prevalence of the arginine catabolic mobile element in carriage 
isolates of methicillin‑resistant Staphylococcus epidermidis. J Antimicrob 
Chemother. 2011;66:29e36.
 45. Bukowski M, Piwowarczyk R, Madry A, Zagorski‑Przybylo R, Hydzik 
M, Wladyka B. Prevalence of antibiotic and heavy metal resistance 
determinants and virulence‑related genetic elements in plasmids of 
Staphylococcus aureus. Front Microbiol. 2019. https ://doi.org/10.3389/
fmicb .2019.00805 .
 46. McCarthy AJ, Loeffler A, Witney AA, Gould KA, Lloyd DH, Lindsay JA. 
Extensive horizontal gene transfer during Staphylococcus aureus co‑
colonization in vivo. Genome Biol Evol. 2014;6(10):2697–708. https ://
doi.org/10.1093/gbe/evu21 4.
 47. Bosch T, Witteveen S, Haenen A, Landman F, Schouls LM. Next‑gen‑
eration sequencing confirms presumed nosocomial transmission of 
livestock‑associated methicillin‑resistant Staphylococcus aureus in the 
Netherlands. Appl Environ Microbiol. 2016;82(14):4081–9. https ://doi.
org/10.1128/AEM.00773 ‑16.
 48. Águila‑Arcos S, Álvarez‑Rodríguez I, Garaiyurrebaso O, Garbisu C, 
Grohmann E, Alkorta I. Biofilm‑forming clinical Staphylococcus isolates 
harbor horizontal transfer and antibiotic resistance genes. Front 
Microbiol. 2018;2017(8):2017. https ://doi.org/10.3389/fmicb .2017.02018 
(eCollection 2017).
 49. Wójcik K. Regulation of virulence factors gene expression in Staphylo-
coccus aureus. Post Mikrobiol. 1997;24(8):77–85.
 50. Arya R, Princy SA. An insight into pleiotropic regulators Agr and Sar: 
molecular probes paving the new way for antivirulent therapy. Future 
Microbiol. 2013;8(10):1339–53. https ://doi.org/10.2217/fmb.13.92.
 51. Arya R, Princy SA. Exploration of modulated genetic circuits governing 
virulence determinants in Staphylococcus aureus. Indian J Microbiol. 
2016;56(1):19–27. https ://doi.org/10.1007/s1208 8‑015‑0555‑3.
 52. Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): Uni‑
versity of Texas Medical Branch at Galveston; 1996. https ://www.ncbi.
nlm.nih.gov/books /NBK76 27.
 53. Akiyama K, Karak M, Mori N. Evaluation of adult potas puffy tumor: our 
five cases and 27 literature cases. Laryngoscope. 2012;122(11):2382–8.
 54. Jeannon JP, Orabi A, Manganaris A, Simo R. Multiresistant Staphylococ-
cus aureus infection as a causative agent of fistula formation following 
total laryngectomy for advanced head & neck cancer. Head Neck Oncol. 
2010;2:14. https ://doi.org/10.1186/1758‑3284‑2‑14.
 55. Brzychczy‑Włoch M, Borszewska‑Kornecka M, Gulczyńska E, 
Wójkowska‑Mach J, Sulik M, Grzebyk M, et al. Prevalence of antibiotic 
resistance in multi‑drug resistant coagulase‑negative staphylococci 
isolated from invasive infection in very low birth weight neonates in 
two Polish NICUs. Ann Clin Microbiol Antimicrob. 2013. https ://doi.
org/10.1186/1476‑0711‑12‑41.
 56. Drago L, Cappelletti L, Lamartina C, Berjano P, Mattina M, DeVecchi E. 
Colonization by methicillin resistant staphylococci of nares and skin in 
healthcare workers: a pilot study in spinal surgeries. Int J Care Injured. 
2015;46(S8):S77–80.
 57. Rogers KL, Fey PD, Rupp ME. Coagulase‑negative staphylococcal 
infections. Infect Dis Clin North Am. 2009;23(1):73–98. https ://doi.
org/10.1016/j.idc.2008.10.001.
 58. Natsis NE, Cohen PR. Coagulase‑negative Staphylococcus skin and soft 
tissue infections. Am J Clin Dermatol. 2018;19(5):671–7. https ://doi.
org/10.1007/s4025 7‑018‑0362‑9.
 59. Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P, et al. Inter‑
national collaboration on endocarditis merged database study group. 
Prosthetic valve endocarditis due to coagulase‑negative staphylococci: 
findings from the international collaboration on endocarditis merged 
database. Eur J Clin Microbiol Infect Dis. 2006;25(6):365–8.
 60. García Mària C, Cervera C, Pericàs JM, Castañeda X, Armero Y, Soy 
D, Hospital clinic endocarditis study group, et al. Epidemiology 
and prognosis of coagulase‑negative staphylococcal endocarditis: 
impact of vancomycin minimum inhibitory concentration. PLoS ONE. 
2015;10(5):e0125818. https ://doi.org/10.1371/journ al.pone.01258 18 
(eCollection 2015).
 61. Vogkou CT, Vlachogiannis NI, Palaiodimos L, Kousoulis AA. The causa‑
tive agents in infective endocarditis: a systematic review comprising 
33,214 cases. Eur J Clin Microbiol Infect Dis. 2016;35(8):1227–45. https ://
doi.org/10.1007/s1009 6‑016‑2660‑6.
 62. Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, 
et al. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014;7(1):25. 
https ://doi.org/10.1186/1939‑4551‑7‑25.
 63. Długaszewska J, Leszczyńska M, Lenkowski M, Tatarska A, Pastusiak T, 
Szyfter W. The pathophysiological role of bacterial biofilms in chronic 
Page 9 of 10Michalik et al. Ann Clin Microbiol Antimicrob           (2020) 19:26  
sinusitis. Eur Arch Othorhinol. 2015. https ://doi.org/10.1007/s0040 
5‑015‑3650‑5.
 64. Anderson M, Stokken J, Sanford T, Aurora R, Sindvani R. A systematic 
review of the sinonasal microbiome in chronic rhinosinusitis. Am J 
Rhinol Allergy. 2016;30(3):161–6.
 65. Manes RP, Batra PS. Bacteriology and antibiotic resistance in chronic 
rhinosinusitis. Facial Plast Surg Clin N Am. 2012;20:87–91.
 66. Zhang Z, Adappa ND, Lautenbach E, Chiu AG, Doghramji LJ, Cohen 
NA, Palmer JN. Coagulase‑negative staphylococcus culture in chronic 
rhinosinusitis. Int Forum Allergy Rhinol. 2015;5(3):204–13.
 67. Yildirim A, Oh C, Erdem H, Kunt T. Bacteriology in patients with chronic 
sinusitis who have been medically and surgically treated. Ear Nose 
Throat J. 2004;83(12):836–8.
 68. Li H, Xu L, Wang J, et al. Conversion of Staphylococcus epidermidis 
strains from commensal to invasive by expression of the ica locus 
encoding production of biofilm exopolysaccharide. Infect Immun. 
2005;73(5):3188–91.
 69. Thanasumpun T, Batra PS. Endoscopically‑derived bacterial cultures 
in chronic rhinosinusitis: a systematic review. Am J Otolaryngol. 
2015;36:686–91.
 70. Bhattacharyya N, Kepnes LJ. The microbiology of recurrent rhinosinusi‑
tis after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg. 
1999;125:1117–20.
 71. Klossek JM, Dubreuil L, Richet H, et al. Bacteriology of chronic purulent 
secrations in chronic rhinosinusitis. J Laryngol Otol. 1998;112:1162–6.
 72. Granville L, Chirala M, Cernoch P, Ostrowski M, Truong LD. Fungal 
sinusitis: histologic spectrum and correlation with culture. Hum Pathol. 
2004;35(4):474–81.
 73. Montone KT. Differential diagnosis of necrotizing sinonasal lesions. Arch 
Pathol Lab Med. 2015;139:1508–14.
 74. Wellinghansen N, Sing A, Kern WV, Perner S, Marre R, Rentschler J. A 
fatal case of necrotizing sinusitis due to toxigenic Corynebacterium 
ulcerans. Int J Med Microb. 2002;292(1):59–63.
 75. Matthews PC, Lazarus R, Protheroe A, Milford C, Bowler IC. J Acute 
necrotizing sinusitis caused by Staphylococcus lugdunensis. J Clin Micro‑
biol. 2011;49(7):2740–2.
 76. You YO, Kim KJ, Min BN, Chung CP. Staphylococcus lugdunensis—a 
potential patogen in oral infections. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod. 1999;88:297–302.
 77. Thomas S, Hoy C, Capper R. Osteomyelitis of the ear canal caused by 
Staphylococcus lugdunensis. J Infect. 2006;53:e227–9.
 78. Goyal M, Javerliat F, Palmieri M, Mirande C, van Wamel W, et al. Genomic 
evolution of Staphylococcus aureus during artificial and natural coloni‑
zation of the human nose. Front Microbiol. 2019;10:1525. https ://doi.
org/10.3389/fmicb .2019.01525 .
 79. Kaspar U, Kriegeskorte A, Schubert T, Peters G, Rudack C, et al. The 
culturome of the human nose habitats reveals individual bacterial 
fingerprint patterns. Environ Microbiol. 2016;18(7):2130–42. https ://doi.
org/10.1111/1462‑2920.12891 .
 80. Międzobrodzki J, Naidu AS, Watts JL, Ciborowski P, Palm K, Wadstrom T. 
Influence of milk on fibronectin and collagen type‑I binding to Staphy-
lococcus aureus and coagulase‑negative Staphylococci isolated from 
bovine mastitis. J Clin Microbiol. 1989;27:540–4.
 81. Jaworek R, Pawliczak R, Międzobrodzki J. Recent opinions on the role 
of acidophilic granulocytes in mechanisms of immunological defense 
and in pathogenesis of selected human diseases. Folia Med Cracov. 
2008;49(3–4):13–22.
 82. Moy BT, Forouhar F, Kuo CL, Devers TJ. Endoscopic features of 
mucous cap polyps: a way to predict serrated polyps. Clin Endosc. 
2018;51(4):368–74. https ://doi.org/10.5946/ce.2017.155.
 83. Bezerra TF, Padua FG, Gebrim EM, Sladiva PH, Voegels RL. Biofilm in 
chronic rhinisinusitis with nasal polyps. Otolaryngol Head Neck Surg. 
2011;144(4):612–6.
 84. Liu Q, Lu X, Bo M, Qing H, Wang X, Zhang L. The microbiology of 
chronic rhinosinusitis with and without nasal polyps. Acta Otolaryngol. 
2014;134:1251–8.
 85. Wei HZ, Li YC, Wang XD, Lu XX, Hu CH, He S, et al. The microbiology of 
chronic rhinosinusitis with and without nasal polyps. Eur Arch Oto‑
Rhino‑Laryngol. 2018;275:1439–47.
 86. Heczko PB, Hoeffler U, Kasprowicz A, Pulverer G. Quantitative studies of 
the flora of nasal vestibule in relation to nasal carriage of Staphylococ-
cus aureus. J Med Microbiol. 1981;14(3):233–41.
 87. Egert M, Simmering R. The microbiota of the human skin. Adv Exp Med 
Biol. 2016;902:61–81. https ://doi.org/10.1007/978‑3‑319‑31248 ‑4_5.
 88. Belkaid Y, Segre JA. Dialogue between skin microbiota and immunity. 
Science. 2014;346(6212):954–9. https ://doi.org/10.1126/scien ce.12601 
44.
 89. Somerville DA. The normal flora of the skin in different age groups. Br J 
Dermatol. 1969;81(4):248–58.
 90. Dubin G, Chmiel D, Mak P, Rachwalska M, Rzychoń M, Dubin A. 
Molecular cloning and biochemical characterization of proteases from 
Staphylococcus epidermidis. Biol Chem. 2001;382:1575–82.
 91. Międzobrodzki J, Kaszycki P, Białecka A, Kasprowicz A. Proteolytic activ‑
ity of Staphylococcus aureus strains isolated from the colonization of 
patients with acute‑phase atopic dermatitis. Eur J Clin Microbiol Infect 
Dis. 2002;21(4):269–76.
 92. Conlan S, Mijares L, NISC Comparative Sequencing Program, Becker J, 
Blakesley RW, Bouffard GG, Brooks S, Coleman H, et al. Staphylococcus 
epidermidis pan‑genome sequence analysis reveals diversity of skin 
commensal and hospital infection‑associated isolates. Genome Biol. 
2012;13(7):R64. https ://doi.org/10.1186/gb‑2012‑13‑7‑r64.
 93. Becker K, Lahom NA, Fegeler W, Proctor RA, Peters G, von Eiff C. Fourier‑
transform infrared spectroscope analysis as a powerful tool for studying 
the dynamic changes in Staphylococcus aureus small colony variants. J 
Clin Microbiol. 2006;44:3274–8.
 94. Lee YL, Cesario T, Tran C, Stone G, Thrupp L. Nasal colonization by 
methicillin‑resistant coagulase‑negative Staphylococcus in com‑
monly skilled nursing facility patients. Amer J Infect Control. 
2000;28(3):269–72.
 95. Kozioł‑Montewka M, Szczepanik A, Baranowicz I, Jóźwiak L, Książek A, 
Kaczor D. The investigation of Staphylococcus aureus and coagulase‑
negative staphylococci nasal carriage among patients undergoing 
haemolysis. Microbiol Res. 2006;161(4):281–7.
 96. Staphylococcal infections. Merck Manual Professional Version. http://
www.merck manua ls.com/profe ssion al/infec tious ‑disea ses/gram‑posit 
ive‑cocci /staph yloco ccal‑infec tions . Accessed Apr. 06, 2020.
 97. Hayden MK, Lolans K, Haffenreffer K, Avery TR, Kleinman K, et al. Chlo‑
rhexidine and mupirocin susceptibility of methicillin‑resistant Staphy-
lococcus aureus isolates in the REDUCE‑MRSA. Trial J Clin Microbiol. 
2016;54(11):2735–42.
 98. Rudresh MS, Ravi GS, Motagi A, Alex AM, Sandhya P. Prevalence of 
mupirocin resistance among Staphylococci, its clinical significance and 
relationship to clinical use. J Lab Physicians. 2015;7(2):103–7. https ://doi.
org/10.4103/0974‑2727.16312 7.
 99. Al‑Ani MZ, Davies SJ, Gray RJ, Sloan P, Glenny AM. Stabilisation splint 
therapy for temporomandibular pain dysfunction syndrome. Cochrane 
Database Syst Rev. 2004. https ://doi.org/10.1002/14651 858.CD002 778.
pub2.
 100. Hyung‑Mo K, Tae‑Wan K, Ju‑Hong H, Dong‑Joo L, Na‑Rae P, Seung‑Il 
SJ. Infection of the temporomandibular joint: a report of three cases. 
J Korean Assoc Oral Maxillofac Surg. 2011;37(6):510–4. https ://doi.
org/10.5125/jkaom s.2011.37.6.510.
 101. Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporo‑
mandibular disorders: a Review. J Can Dent Assoc. 2017;83:h7.
 102. Kessler B, Sendi P, Graber P, Krupp M, Zwicky L, Hintermenn B, et al. Risk 
factors for periprosthetic ankle joint infection: a case‑control study. J 
Bone Joint Surg. 2012;94(20):1871–6.
 103. Chisnoiu AM, Picos AM, Popa S, Chisnoiu PD, Lascu L, Picos A, et al. 
Factors involved in the etiology of temporomandibular disorders–a 
literature review. Clujul Med. 2015;88(4):473–8. https ://doi.org/10.15386 
/cjmed ‑485.
 104. Chidzonga MM. Temporomandibular joint ankylosis: review of thirty 
two cases. Br J Oral Surg. 1999;37(2):123–6.
 105. Lupton DE. Psychological aspects of temporomandibular joint dysfunc‑
tion. J Am Dent Assoc. 1969;79(1):131–6.
 106. Kim T, Kandiah S, Patel M, Rab S, Wong J, et al. Risk factors for kidney 
injury during vancomycin and piperacillin/tazobactam administration, 
including increased odds of injury with combination therapy. BMC Res 
Notes. 2015;8:579. https ://doi.org/10.1186/s1310 4‑015‑1518‑9.
Page 10 of 10Michalik et al. Ann Clin Microbiol Antimicrob           (2020) 19:26 
 107. Winters SE. Staphylococcus infection of the temporomandibular joint. 
Oral Surg Oral Med Oral Pathol Oral Radiol. 1955;8(2):148–50.
 108. Malachovsky I, Janickova M, Stasko J, Kasaj M, Sadlonova V, Novakova 
E, et al. Pseudomonas infection of the temporomandibular joint (TMJ) 
Health and Public Health Issues. Acta Medica Martiniana. 2017;17(1):33–
9. https ://doi.org/10.1515/acm‑2017‑0005.
 109. Butt HL, Dunstan RH, McGregor NR, Roberts TK, Zerbes M, Klineberg TJ. 
An association of membrane‑damaging toxins from coagulase‑nega‑
tive staphylococci and chronic orofacial muscle pain. J Med Microbiol. 
1998;47:577–84.
 110. Tevell S, Hellmark B, Nilsdotter‑Augustiansson A, Soderquist B. Staphy-
lococcus capitis isolated from prosthetic joint infections. Eur J Clin 
Microbiol Infec Dis. 2017;36:115–22.
 111. McGregor NR, Zerbes M, Niblett SH, Dunstan RH, Roberts TK, Butt HL, 
et al. Coagulase‑negative Staphylococcal membrane‑damaging toxins, 
pain intensity and metabolic changes in temporomandibular disorder 
patients with chronic muscle pain. J Orofacial Pain. 2003;17(2):125–32.
 112. Metcalf LN, McGregor NR, Roberts TK. Membrane damaging toxins from 
coagulase‑negative Staphylococcus are associated with self‑reported 
temporomandibular disorders (TMD) in patients with chronic fatigue 
syndrome. J Chronic Fatigue Syndr. 2004;12(3):25–43.
 113. Guo G, Wang J, You Y, Tan J, Shen H. Distribution characteristics of 
Staphylococcus spp. in different phases of periprosthetic joint infection: 
a review. Exp Therapeutic Med. 2017;13:2599–608.
 114. Uckay L, Harbarth S, Ferry T, Lubbeke A, Emonet S, Hoffmeyer P, et al. 
Methicillin resistance in orthopaedic coagulase‑negative staphylococ‑
cal infections. J Hosp Infect. 2011;79:248–53.
 115. Triffault‑Fillit C, Ferry T, Laurent F, Pradat P, Dupieux C, Lyon BJI Study 
Group, et al. Microbiologic epidemiology depending on time to occur‑
rence of prosthetic joint infection: a prosoective cohort study. Clin 
Microbiol Infect. 2019;25(3):353–8.
 116. Armstrong DG, Lanthier J, Lelievre P, Edelson GW. Methicillin‑resistant 
coagulase‑negative staphylococcal osteomyelitis and its relationship to 
broad‑spectrum oral antibiosis in a predominantly diabetic population. 
J Foot Ankle Surg. 1995;34(6):563–6.
 117. Loiez C, Wallet F, Pischedda P, Renaux E, Senneville E, Mehdi N, et al. 
First case of osteomyelitis caused by Staphylococcus pettenkoferi. J Clin 
Microbiol. 2007;45(3):1067–71.
 118. Johnson AK, Batra PS. Central skull base osteomyelitis: an emerg‑
ing clinical entity. Laryngoscope. 2014;124(5):1083–7. https ://doi.
org/10.1002/lary.24440 .
 119. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE, Foreign‑Body 
Infection (FBI) Study Group. Role of rifampin for treatment of orthope‑
dic implant‑related staphylococcal infections: a randomized controlled 
trial. JAMA. 1998;279(19):1537–41.
 120. Wilk I, Ekiel A, Kłuciński P, Krzysztoń‑Russjan J, Martirosian G. Charac‑
terization of coagulase‑negative staphylococci isolated from cases of 
ostitis and osteomyelitis. Pol J Microbiol. 2006;55(3):175–8.
 121. Haeffs TH, Scott CA, Cambell TH, Chen Y, August M. Acute and chronic 
suppurative osteomyelitis of the jaws: a 10‑years review and assess‑
ment of treatment outcome. J Oral Maxillofac Surg. 2018;76(12):2552–8.
 122. Deepak S, Samant SA, Urhekar AD. Study of coagulase positive 
and negative Staphylococci in clinical samples. Indian J Med Sci. 
1999;53(10):425–8.
 123. Giedrys‑Kalemba S, Hałasa J, Podkowińska I. Persistance of Staphylococ-
cus aureus in the pharynx of children with chronic tonsilitis treated with 
autovaccine. Pediatr Pol. 1985;60:761–7.
 124. Thattil SS, Santosh S, Ajith TA. Staphylococcus associated acute throat 
infection among children presented to a tertiary care hospital. Int J Res 
Med Sci. 2018;6(10):3287–92.
 125. Katkowska M, Garbacz K, Stromkowski J. Staphylococcus aureus isolated 
from tonsillectomized adult patients with recurrent tonsillitis. APMIS. 
2017;125:46–51.
 126. Zautner AE, Krause M, Stropahl G, Holtfreter S, Frickmann H, Maletzki 
C, et al. Intracellular persisting Staphylococcus aureus is the major 
pathogen in recurrent tonsilitis. PLoS One. 2010;5(3):e9452. https ://doi.
org/10.1371/journ al.pone.00094 52.
 127. Kuhn JJ, Brook I, Walters CL, Church LW, Bianchi DA, Thompson DH. 
Quantitative bacteriology of tonsils removed from children with tonsil‑
litis hypertrophy and recurrent tonsillitis with and without hypertrophy. 
Ann Otol Rhinol Laryngol. 1995;104(8):646–52.
 128. Jayashima VL, Vinodkumar CS, Raghukumar KG, Basavarajappa KG. 
Surface tonsillar bacteria versus deep tonsillar bacteria in tonsillitis. J 
Pub Health Med Res. 2013;1(2):92–4.
 129. Abraham ZS, Bazilia J, Kahinga AA, Manyahi J, Ntunaguzi D, Mas‑
sawe ER. Patients attending otorhinolaryngology department at 
Muhimbili National Hospital, Dar es Salam—Tanzania. Med J Zambia. 
2019;46(1):33–40.
 130. Miszke A, Kasprowicz A, Heczko PB. Quantitative analysis of aerobic and 
microaerophilic bacterial flora of palatine tonsils in patients with recur‑
rent tonsillitis. Otolaryngol Pol. 1987;41:396–401.
 131. Ayeni FA, Andersen C, Nørskov‑Lauritsen N. Comparison of growth on 
mannitol salt agar, matrix‑assisted laser desorption/ionization timeof‑
flight mass spectrometry, VITEK 2 with partial sequencing of 16S rRNA 
gene for identification of coagulase‑negative staphylococci. Microb 
Pathog. 2017;105:255–9. https ://doi.org/10.1016/j.micpa th.2017.02.034.
 132. Becker K, Harmsen D, Mellmann A, Meier C, Schumann P, Peters G, 
et al. Development and evaluation of a qualitycontrolled ribosomal 
sequence database for 16S ribosomal DNA‑based identification of 
Staphylococcus species. J Clin Microbiol. 2004;42:4988–95. https ://doi.
org/10.1128/JCM.42.11.4988‑4995.2004.
 133. Kosecka‑Strojek M, Ilczyszyn WM, Buda A, Polakowska K, Murzyn K, 
et al. Multiple‑locus variable‑number tandem repeat fingerprinting 
as a method for rapid and cost‑effective typing of animal‑associated 
Staphylococcus aureus strains from lineages other than sequence type 
398. J Med Microbiol. 2016;65(12):1494–504. https ://doi.org/10.1099/
jmm.0.00037 8.
 134. LisowskaŁysiak K, Kosecka‑Strojek M, Białecka J, Kasprowicz A, Garbacz 
K, et al. New insight into genotypic and phenotypic relatedness 
of Staphylococcus aureus strains from human infections or animal 
reservoirs. Pol J Microbiol. 2019;68(1):93–104. https ://doi.org/10.21307 /
pjm‑2019‑011.
 135. Sabat AJ, van Zanten E, Akkerboom V, Wisselink G, van Slochteren K, 
de Boer RF, et al. Targeted next‑generation sequencing of the 16S‑23S 
rRNA region for culture‑independent bacterial identification‑ increased 
discrimination of closely related species. Sci Rep. 2017;7:3434. https ://
doi.org/10.1038/s4159 8‑017‑03458 ‑6.
 136. Kosecka‑Strojek M, Sabat AJ, Akkerboom V, Kooistra‑Smid AMDM, 
Miedzobrodzki J, Friedrich AW. Development of a reference data set for 
assigning Streptococcus and Enterococcus species based on next gen‑
eration sequencing of 16S–23S rRNA region. Antimicrob Resist Infect 
Control. 2019;8:178. https ://doi.org/10.1186/s1375 6‑019‑0622‑3.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
